World-class
Scientific Advisory

Work with Richmond Pharmacology and trust your experience will be personal and truly strategic.

Keith Berelowitz, MSc
Director of Operations

A scientist by training, Keith has worked in clinical research (academic and commercial) for over 14 years, having spent the majority of that period working for Richmond Pharmacology. In his role as Director of Operations at Richmond Pharmacology he is focused on the efficient conduct of all functions within the company whilst ensuring maintenance of quality standards.

Having played an operational role in over 150 studies, across the commercial, project and recruitment related management of these studies, his specialist area of interest has focused on the assessment and understanding of the feasibility of conducting early phase patient trials in a phase I environment. Keith has worked with a number of sponsors advising them on the viability of conducting such trials within the UK, a number of which have gone on to be conducted successfully with Richmond Pharmacology.


He is a member of the National Research Ethics Service Phase I Advisory Group (Health Research Authority, UK), the Association for Human Pharmacology in the Pharmaceutical Industry (AHPPI, UK), Chairperson of the EUCROF Early Phase Working Group, the UK representative of the EUCROF Extended Executive Board, and a Member of the Executive Board of the Clinical Contract Research Association (CCRA).

Back to experts

Latest news

Upcoming Event

ACCP 2020, Translating Clinical Pharmacology Research into Patient-centered Care

21 - 23 September 2020
Dr. Jorg Taubel will be presenting posters that explore the subjects of cardiac health and diabetes.
View event

Richmond Pharmacology supports ReViral with the development of Sisunatovir

September 9, 2020
ReViral has confirmed the FDA has granted Fast Track designation to Sisunatovir.
Read more

Richmond Pharmacology helps UK patients gain early access to ultra-rare disease drug Lumasiran

August 17, 2020
Richmond Pharmacology early phase drug development update.
Read more

Dr Jorg Taubel, CEO of Richmond Pharmacology, features on the PM Live website, discussing clincial trials and COVID-19

August 11, 2020
Dr Jorg Taubel discusses some of the steps taken at Richmond Pharmacology to ensure clinical trials can continue to operate at a high standard throughout the COVID-19 pandemic.
Read more